我是 LongbridgeAI，我可以總結文章信息。醫療保健股票上漲，因為投資者轉向對燃料價格和利率不那麼敏感的行業。諾和諾德公司計劃重新品牌為 “Novo”，以更好地與消費者產生共鳴，抵禦競爭對手禮來的挑戰。與此同時，阿斯利康的新型乳腺癌藥物未能達到其主要臨牀試驗目標，即減緩疾病進展，但其股價仍然上漲
Health-care companies rose as traders rotated into sectors less susceptible to rising fuel prices and interest rates.
Wegovy maker Novo Nordisk plans to rebrand itself as Novo, betting a shorter name will help it resonate more with consumers as it competes with rival Eli Lilly.
AstraZeneca said its new breast-cancer pill missed the key goal of slowing the disease from worsening in a late-stage clinical trial. Shares of the British drug maker still gained.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
September 14, 2026 18:20 ET (22:20 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.